T Dörner Selected Research

T Dörner Research Topics

Disease

18	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2020 - 01/2000
16	Autoimmune Diseases (Autoimmune Disease) 05/2020 - 09/2000
11	Rheumatic Diseases (Rheumatism) 06/2020 - 01/2006
9	Rheumatoid Arthritis 04/2020 - 06/2009
5	Infections 04/2020 - 01/2000
4	Connective Tissue Diseases (Connective Tissue Disease) 06/2020 - 01/2002
4	Myositis (Idiopathic Inflammatory Myopathies) 02/2018 - 09/2000
3	Vasculitis (Vasculitides) 02/2018 - 02/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2010 - 07/2008
2	Psoriatic Arthritis 04/2020 - 07/2008
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019 - 05/2007
2	Fever (Fevers) 02/2018 - 02/2018
2	Communicable Diseases (Infectious Diseases) 12/2017 - 01/2000
2	Hemolysis 06/2008 - 09/2003
2	Lymphoma (Lymphomas) 12/2007 - 01/2006
2	Congenital heart block 02/2005 - 09/2000
2	Type 1 Hyper-IgM Immunodeficiency Syndrome 07/2001 - 06/2000
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2020
1	Autoimmune Hepatitis 06/2020
1	Pregnancy Complications 05/2020
1	Atopic Dermatitis (Atopic Eczema) 04/2020
1	Ulcerative Colitis 04/2020
1	Ankylosing Spondylitis 04/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2018
1	Cryopyrin-Associated Periodic Syndromes 02/2018
1	Adult-Onset Still's Disease 02/2018
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 02/2018
1	Familial Mediterranean Fever (Periodic Disease) 02/2018
1	Pemphigus (Pemphigus Vulgaris) 02/2018
1	Diverticulitis 02/2018
1	Dermatomyositis (Dermatopolymyositis) 02/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Neoplasms (Cancer) 12/2017
1	Multiple Sclerosis 03/2016
1	Neuromyelitis Optica (Devic's Disease) 03/2016
1	Fatigue 02/2016
1	Castleman Disease (Castleman's Disease) 04/2014
1	Inflammation (Inflammations) 04/2014
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2014
1	Proteinuria 10/2013
1	Systemic Vasculitis 02/2013
1	Chronic Disease (Chronic Diseases) 12/2011
1	Necrosis 12/2011
1	Immune System Diseases (Immune Disorders) 03/2011
1	Progressive Multifocal Leukoencephalopathy 09/2010
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2008

Drug/Important Bio-Agent (IBA)

14	AutoantibodiesIBA 09/2012 - 09/2000
12	Rituximab (Mabthera)FDA Link 02/2018 - 12/2007
10	Biological ProductsIBA 04/2020 - 12/2008
8	AntibodiesIBA 06/2020 - 09/2000
5	Pharmaceutical PreparationsIBA 06/2020 - 09/2003
4	Tumor Necrosis Factor InhibitorsIBA 03/2014 - 09/2010
3	CytokinesIBA 04/2020 - 09/2012
3	EpitopesIBA 01/2018 - 02/2005
3	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2008 - 09/2000
3	Immunoglobulin Variable RegionIBA 03/2005 - 09/2000
2	Antinuclear AntibodiesIBA 06/2020 - 09/2000
2	Antiphospholipid AntibodiesIBA 05/2020 - 05/2007
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2020 - 04/2012
2	AnticoagulantsIBA 01/2019 - 05/2007
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2018 - 02/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 03/2014
2	Infliximab (Remicade)FDA Link 02/2018 - 01/2018
2	Complement System Proteins (Complement)IBA 02/2016 - 10/2013
2	Monoclonal AntibodiesIBA 02/2016 - 09/2010
2	Immunoglobulins (Immunoglobulin)IBA 02/2016 - 04/2008
2	Biomarkers (Surrogate Marker)IBA 11/2015 - 12/2011
2	Glycoproteins (Glycoprotein)IBA 04/2014 - 05/2007
2	AntigensIBA 09/2012 - 01/2006
2	Immunoglobulin G (IgG)IBA 09/2010 - 03/2001
2	Proteins (Proteins, Gene)FDA Link 02/2005 - 01/2002
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 05/2020
1	baricitinibIBA 04/2020
1	upadacitinibIBA 04/2020
1	Antirheumatic Agents (DMARD)IBA 04/2020
1	Janus Kinase InhibitorsIBA 04/2020
1	GLPG0634IBA 04/2020
1	peficitinibIBA 04/2020
1	tofacitinibIBA 04/2020
1	CT-P13IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	SRI-5 (SRI 5)IBA 02/2016
1	tabalumabIBA 02/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016
1	Estrogens (Estrogen)FDA Link 02/2016
1	B-Cell Activating FactorIBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2014
1	tocilizumab (atlizumab)FDA Link 04/2014
1	Genetic Markers (Genetic Marker)IBA 12/2011
1	Vitamin D FDA LinkGeneric 03/2011
1	Anti-Citrullinated Protein AntibodiesIBA 06/2009
1	Protein-Arginine Deiminase Type 4IBA 06/2009
1	cyclic citrullinated peptideIBA 06/2009

Therapy/Procedure

15	Therapeutics 02/2018 - 01/2000
3	Biological Therapy 02/2018 - 02/2018
1	Secondary Prevention 05/2020
1	Off-Label Use 02/2018
1	Kidney Transplantation 02/2018
1	Precision Medicine 02/2013
1	Contraindications 09/2010